Home  >  Products  >  AP2A2 (adaptor-related protein complex 2, alpha 2 subunit) Blocking Peptide (the C terminal of AP2A2)(100ug)
AP2A2 (adaptor-related protein complex 2, alpha 2 subunit) Blocking Peptide (the C terminal of AP2A2)(100ug)

AP2A2 (adaptor-related protein complex 2, alpha 2 subunit) Blocking Peptide (the C terminal of AP2A2)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-AP2A2 Antibody (ARP59974_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP59974
Size: 100ug
Weight: 55kDa
Gene: 158
Format: Lyophilized powder
Target: Adenylsuccinate lyase is involved in both de novo synthesis of purines and formation of adenosine monophosphate from inosine monophosphate. It catalyzes two reactions in AMP biosynthesis: the removal of a fumarate from succinylaminoimidazole carboxamide (SAICA) ribotide to give aminoimidazole carboxamide ribotide (AICA) and removal of fumarate from adenylosuccinate to give AMP. Adenylosuccinase deficiency results in succinylpurinemic autism, psychomotor retardation, and , in some cases, growth retardation associated with muscle wasting and epilepsy. Two transcript variants encoding different isoforms have been found for this gene.
Alternative names: AMPS; ASASE; ASL
See Full Product Listings >